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Abstract: Sinonasal-related orbital infections (SROIs) are typically pediatric diseases that occur in
3–4% of children with acute rhinosinusitis. They are characterised by various clinical manifestations,
such as peri-orbital and orbital cellulitis or orbital and sub-periosteal abscesses that may develop
anteriorly or posteriorly to the orbital septum. Posterior septal complications are particularly
dangerous, as they may lead to visual loss and life-threatening events, such as an intracranial
abscess and cavernous sinus thrombosis. Given the possible risk of permanent visual loss due
to optic neuritis or orbital nerve ischemia, SROIs are considered ophthalmic emergencies that
need to be promptly recognised and treated in an urgent-care setting. The key to obtaining
better clinical outcomes in children with SROIs is a multi-disciplinary assessment by pediatricians,
otolaryngologists, ophthalmologists, radiologists, and in selected cases, neurosurgeons, neurologists,
and infectious disease specialists. The aim of this paper is to provide an overview of the pathogenesis,
clinical manifestations, diagnosis, and treatment of pediatric SROIs, and to make some practical
recommendations for attending clinicians.
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1. Introduction and Definitions
Sinonasal-related orbital infections (SROIs) are typically pediatric diseases that occur in about
3–4% of children with acute rhinosinusitis [1], and mainly affect children aged less than five
years [2]. They are generally due to ethmoidal sinusitis spreading to the orbit, and are more frequent
during winter.
SROIs are characterised by various clinical manifestations that may develop anteriorly or
posteriorly to the orbital septum, a thin fibrous membrane extending from the orbital rims to the eyelids
(the anterior boundary of the orbit) that acts as a barrier against the spread of external infections to
the deep orbit. Chandler’s classification [3] distinguishes pre-septal complications, such as pre-septal
cellulitis (POC, Chandler stage 1), which affects the eyelids and adnexa, without extending beyond
the peri-orbit, from the more dangerous infections that develop posteriorly to the orbital septum,
i.e., orbital cellulitis (OC, Chandler stage 2), sub-periosteal abscess (SPA, the collection of pus in the
lamina papyracea, Chandler stage 3) (Figure 1), or orbital abscess (OA, Chandler stage 4) (Figure 2).
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Chandler stage 5 disease refers to cavernous sinus thrombosis (Table 1). Posterior septal complications
are particularly dangerous, as they may lead to visual loss and life-threatening events, such as an
intracranial abscess and cavernous sinus thrombosis. SPA accounts for 9–28% of all SROIs [4,5], and is
generally secondary to ethmoiditis; it is more frequently located in the medial portion of the orbit [6],
but other less frequent locations include superior and superomedial SPA generally due to frontal
sinusitis [6]. Some authors have suggested that osteitis of the lamina papyracea occurring during acute
ethmoiditis may play an etiological role in the development of SPA [7], as it is detected in more than
55% of cases.
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causing proptosis. (B) Computed tomography (CT) findings demonstrating bilateral ethmoiditis and 
sphenoidal sinusitis—the white arrow indicates the presence of right ethmoiditis, while the black 
arrow indicates a sub-periosteal abscess of the intra-orbital portion of the lamina papyracea. (C) The 
same patient 10 days after combined endoscopic surgery and external lower lid incision. 
 
Figure 2. (A) A 13-year-old patient with acute maxillary sinusitis, an orbital abscess, and meningitis. 
(B) MR findings—the white arrow indicates the presence of right maxillary sinusitis, while the black 
arrow indicates an intraconal abscess located in the lateral portion of the orbit. (C) The same patient 
seven days after combined endoscopic surgery and an external upper lid incision. 
  
Figure 1. (A) A 3-year-old patient with a right sub-periosteal abscess extending to the lower lid and
causing proptosis. (B) Computed tomography (CT) findings demonstrating bilateral ethmoiditis and
sphenoidal sinusitis—the white arrow indicates the presence of right ethmoiditis, while the black arrow
indicates a sub-periosteal abscess of the intra-orbital portion of the lamina papyracea. (C) The same
patient 10 days after combined endoscopic surgery and external lower lid incision.
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Figure 2. (A) A 13-year-old patient with acute maxillary sinusitis, an orbital abscess, and meningitis.
(B) MR findings—the white arrow indicates the presence of right maxillary sinusitis, while the black
arrow indicates an intraconal abscess located in the lateral portion of the orbit. (C) The same patient
seven days after combined endoscopic surgery and an external upper lid incision.
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Table 1. Chandler’s classification of sinonasal-related orbital infections [3]. Note: * = cellulitis affecting
the eyelids and adnexa without extending beyond the peri-orbit; ** = collection of pus between the
periorbita and the orbital wall.
Stage Description
1 Pre-septal cellulitis *
2 Orbital cellulitis
3 Sub-periosteal orbital abscess **
4 Orbital abscess
5 Cavernous sinus thrombosis
However, it has been suggested that SROIs may be clinically better defined by the presence or
absence of any abscess, and its location within the orbit or in the sub-periosteal plane, rather than by
discriminating its pre- and post-septal extension [8].
The clinical presentation of SROIs includes swelling and redness around the eye, and possibly a
temperature and impaired general condition, which are generally more frequent in the case of orbital
involvement. The clinical signs suggesting post-septal complications due to increased intra-orbital
pressure are proptosis, chemosis, ophthalmoplegia, diplopia, impaired visual acuity, or impaired
red-green visual perception [9]. Although proptosis and ophthalmoplegia are strong predictors of
advanced disease [10], computed tomography (CT) findings cannot differentiate OC from OA, and may
be absent in some patients with intra-orbital involvement [10]. It has been reported that proptosis
and ophthalmoplegia may be absent in up to 50% of patients in Chandler stage ≥3 [11], and so some
authors have suggested that, in addition to a clinical examination, consideration should be given to
other predictors, such as a high neutrophil count, older age, and a body temperature of >39 ◦C [10,12].
SROIs are ophthalmic emergencies that need to be promptly recognised and treated in an
urgent-care setting because of the possible risk of permanent visual loss due to optic neuritis or
orbital nerve ischemia following orbital compression or stretching secondary to sub-periosteal or
intra-orbital collections or orbital vein thrombosis. Life-threatening sequelae, such as cavernous sinus
thrombosis, meningitis, and epidural or sub-dural abscess, may also occur as a result of intracranial
spreading [13–15].
The aim of this paper is to provide an overview of the pathogenesis, diagnosis, and treatment of
pediatric SROIs, and make some practical recommendations for attending clinicians.
2. Etiopathogenesis and Differential Diagnosis
Unlike adults (in whom SROIs are less common and are generally due to frontal sinonasal
disease) [13], children with SROIs are mainly affected by acute ethmoiditis, because the development
of the frontal (and maxillary) sinuses is completed by the age of 10–12 years, whereas the ethmoid
labyrinth is generally well developed and pneumatised in newborns [13]. It must also be remembered
that the lamina papyracea (the lateral wall of the ethmoid sinus and its boundary with the adjacent
orbital cavity) is generally thinner and more porous in children, and that venous outflow from the
ethmoid to the intracranial district throughout the orbit can allow the passage of hematogenous
infections in both an antero- and retrograde direction [2].
Although complicated sinonasal disease is the most frequent etiological factor in children with
orbital or peri-orbital cellulitis (its reported incidence ranged from 60% to 91% of cases) [16,17], orbital
swelling alone is non-specific and not pathognomonic for complicated sinusitis, and so physicians
should also consider other conditions that may evolve into even severe disease. These include
dacryocystitis or dacryoadenitis, dental abscesses, insect bites or stings, maxillofacial and orbital
traumas, foreign bodies, neoplasms [12,13], allergic conjunctivitis or allergic reactions, acute sickle
cell orbitopathy (i.e., orbital infarctions or sub-periosteal hematomas in patients with sickle cell
disease), and idiopathic orbital inflammatory disease [18–21]. SROIs should also be differentiated from
other infrequent conditions possibly causing peri-orbital swelling, such as orbital pseudo-tumour,
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orbital myositis, Wegener’s granulomatosis, sarcoidosis, leukemia, Burkitt’s lymphoma, histiocytosis,
and dysthyroid orbitopathy [2].
SROIs are generally due to the bacteria involved in acute rhinosinusitis: the species most
frequently isolated from purulent secretions are Haemophilus influenzae type B, Streptococcus pneumoniae,
Staphylococcus aureus, Staphylococcus epidermidis, and Streptococcus pyogenes [22]. According to some
studies, Streptococcus group A and Streptococcus anginosus are occasionally isolated from pus collected
from SPAs and seem to predispose patients to intracranial complications [23]. Other authors have
reported a high prevalence of Staphylococcus aureus in samples collected from patients with SROIs,
and have highlighted the emerging etiological role of methicillin-resistant strains [24].
Furthermore, even after the introduction of Haemophilus influenzae type B vaccination,
non-typeable Haemophilus influenzae has been documented in about 13% of cultures of fluid collected
after the surgical drainage of an orbital abscess, and is still a major causal agent [15].
3. Diagnosis
A multi-disciplinary clinical assessment should evaluate a patient’s general appearance (in order
to detect fever and any signs of possible systemic toxicity or neurological involvement, such as seizures,
focal neurological defects, vomiting, or altered mental status) and local conditions, taking particular
care to differentiate pre- and post-septal infections (Figures 1 and 2). Visual acuity and eye movements
should be assessed on a daily basis. Although there is no consensus concerning the ideal frequency
of visual examination (with suggestions ranging from every two hours to twice a day) [25], at least
twice a day is recommended [14]. Fundoscopy should also be considered in the case of suspected optic
nerve impairment. Children with pre-septal involvement are generally systemically well, but signs of
systemic involvement (including fever) may occur more frequently if the infection spreads beyond the
orbital septum [26].
A local examination generally reveals unilateral eyelid and peri-orbital swelling, tenderness,
erythema, and warmth. The clinical signs suggesting possible intra-orbital involvement are an inability
to open the eye sufficiently to allow examination, proptosis, ophthalmoplegia, and diplopia, impaired
vision (reduced acuity or the loss of perception of the colour red), asymmetrical pupillary reactivity,
chemosis, or injection of the conjunctiva or sclera [26]. An otolaryngological examination using
nasal fibre endoscopy is useful for exploring the nasal cavities, the middle and superior meatus
and osteomeatal complex, and the sphenoethmoidal recess, in order to detect any sign of sinus
disease (including mucosal edema and purulent secretion) and guide the collection of samples for
microbiological analysis.
Children with uncomplicated POC do not need to undergo routine baseline imaging [27], but if
available and provided that it does not delay any further treatment, urgent magnetic resonance imaging
(MRI) with gadolinium enhancement is the method of choice for localising and diagnosing an abscess
in the case of suspected intra-orbital involvement (or if the impossibility of inspecting the eye during a
bedside examination cannot rule it out), clinical deterioration, no response to intravenous antibiotic
treatment after >48 h, or suspected intracranial extension. The alternative is contrast-enhanced
computed tomography (CT) of the orbit, the maxillo-facial unit, and the brain [26,28]. The diagnostic
accuracy of CT in detecting OC, OA, or SPA ranges from 91% to 100% [29,30], and its pre-surgical use
is essential to plan the treatment of the primary sinonasal focus and guide the surgical drainage of
any intra-orbital or sub-periosteal collection. It can also aid surgeons in identifying the level of the
cribriform plate, and any abnormal bony and vascular structures.
In the case of a neurological deficit, persistent fever despite adequate treatment, or positive brain
CT findings, an urgent MRI scan of the brain and orbits should be carried out provided that it does not
delay further treatment.
Laboratory tests, including assessment of white blood cell counts and serum C-reactive protein
levels may be useful, as inflammatory markers are generally higher in children with SROIs than in
those with peri-orbital cellulitis unrelated to complicated rhinosinusitis; it has also been reported that
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the presence of fever, a white blood cell count of >11,100 per microlitre, and proptosis are independent
predictors of SPA or OA [31].
In the case of suspected sepsis or meningitis, further investigations, such as blood cultures and a
lumbar puncture, should be considered [32].
4. Treatment
Hospital admission should be proposed even in initial disease stages, because given the possibility
of the infection spreading to the intra-orbital or intracranial compartment, this would allow close
in-house clinical monitoring. There is no agreement concerning the ideal treatment of SROI, but current
evidence suggests that parenteral medical treatment should be considered first and immediately started
in the case of POC [14]. Conservative treatment with close clinical monitoring should also be considered
in children with OC [33].
The initial medical treatment consists of intravenous antibiotics that cover the most widely
involved pathogens and provide adequate penetration of the central nervous system in order to
decrease the risk of intracranial diffusion. These schedules include clindamycin plus third-generation
cephalosporin, vancomycin with or without meropenem, ampicillin-sulbactam, and third-generation
cephalosporin plus metronidazole [13,14,34–36].
Topical intranasal medication with decongestants is essential to improve the patency of the
osteomeatal complex and facilitate sinonasal drainage; nasal irrigations with saline or (better)
hypertonic solutions should be considered as complementary treatments.
In the case of multiple foci of bacterial infections, children aged >9 years, or those with known
immunodeficiency, surgery should be considered if there is no improvement >48 h after parenteral
antibiotic treatment [16,37]. SPA and OC (with or without intracranial complications) are considered
emergencies and were traditionally managed by means of immediate surgical drainage; however,
the therapeutic management of SPA has recently been widely debated and there is no consensus
concerning the need for or timing of surgery.
The published success rates of the different means of treating SPA range from 26% to 94.5% [38–41].
A conservative medical approach with close observation is proposed for patients without impaired
visual acuity or increased intra-ocular pressure, with the option of surgery in the case of worsening
ophthalmological findings or a lack of improvement after 48 h [13]. Some evidence suggests that
medical treatment is more effective in children aged <9 years than in older children [41,42]. It has
also been reported that SPA volume as revealed by CT is a significant prognostic factor that can
be considered when selecting patients for surgery, but the cut-off values above which surgery is
required very widely, from 0.48 mL to 3.8 mL [18,37,43]. Abscess width has been investigated as a
possible criterion for surgery, but the results are conflicting—some authors have found that abscesses
of <10 mm can be successfully managed by means of medical treatment alone [5], whereas others
advocate immediate surgery in the case of abscesses of ≥4 mm [40]. However, most authors [39,43,44]
strongly recommend the early surgical treatment of any SPA of≥500 mm3 (~0.5 mL), because although
it has been reported that these can be effectively managed medically, it requires longer hospitalisation
and the administration of antibiotics [44]. Different cut-off values of SPA volume for surgical indication
have been proposed, but the results cannot be compared because of the different criteria used to
quantify the exact volume.
In terms of surgical approaches, endoscopic sinus surgery (ESS) has proved to be effective
in treating SPA and OA, with the surgical goals of draining the abscess, restoring intra-orbital
pressure and the patency and drainage of the sinonasal complex, and collecting samples for culture.
The surgical steps include uncinectomy, middle meatal antrostomy, ethmoidectomy, and penetration
of the lamina papyracea. However, although this procedure seems to be appropriate in the case of
medial locations (including those with a posterior extension) [39,43,45], it is generally believed that
a superomedial location can be better managed by combining ESS with an external superior orbital
rim incision [40,43,45]. Superiorly located SPAs generally require an external approach [43], but a
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combined endonasal endoscopic and external approach should be considered in the case of the most
laterally located superior SPAs [43].
5. Conclusions and Practical Recommendations
The key to obtaining better clinical outcomes in children with SROIs is a multidisciplinary
assessment by pediatricians, otolaryngologists, ophthalmologists, radiologists, and in selected cases,
neurosurgeons, neurologists, and infectious disease specialists (Figure 3). Hospital admission and
close clinical and ophthalmological observation, particularly aimed at ensuring the prompt detection
of any sign suggesting intra-orbital involvement, is essential. Imaging studies should be considered
in the case of suspected intra-orbital or intracranial extension, the impossibility of inspecting the eye,
clinical deterioration, or a clinical non-response to 24–48 h of antibiotic treatment.
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Figure 3. Diagnostic and therapeutic strategies in patients with sinonasal-related orbital infections.
ENT: ear, nose and throat; SPA: subperiosteal abscess; OA: orbital abscess; CT: computed tomography;
MR: magnetic resonance. ∆ Lid swelling and redness with proptosis, eyeball displacement, impaired
ocular motility, visual loss, chemosis. ∆∆ Topical intranasal medication with decongestants, parenteral
antibiotics (ampicillin-sulbactam (100 mg/kg/die in three doses) or cefotaxime (100 mg/kg/die in three
doses) or cephtriaxone (100 mg/kg/die in one dose). ** Amoxicillin plus clavulanic acid (90 mg/kg/die
in three doses) for two weeks. ˆ Provided that it does not delay surgery. ˆˆ In the case of a small SPA
without impaired visual acuity or increased intra-ocular pressure, surgery can be delayed until after
the failure of medical treatment.
Intravenous antibiotic treatment should be started immediately, and can be effective as first-line
therapy in patients with POC and OC.
Surgical treatment by means of ESS or an external approach, or both, depending on location,
should be used in patients with SPA, OC, or intracranial complications in an emergency setting.
It should also be considered if no improvement is observed 24–48 h after parenteral antibiotic treatment
in the case of multiple bacterial infections, and in children aged >9 years or those with known
immunodeficiency [16,37].
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In patients with a small SPA without impaired visual acuity or increased intra-ocular pressure,
surgery can be considered as a second step in the case of worsening ophthalmological findings or no
improvement after 48 h.
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